IndraLab

Statements

USP22 increases the amount of ABCC1. 2 / 2

| 2

reach

"Notably, upregulation of USP22 increases ABCC1 expression and subsequently contributes to sorafenib resistance in hepatocellular carcinoma (HCC) cells, suggesting that USP22 may serve as a therapeutic target for surmounting sorafenib resistance [66]."

36694209

➶

reach

"During sorafenib treatment, upregulation of USP22 increases ABCC1 expression and subsequently contributes to sorafenib resistance in HCC cells."

35203285

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP22 increases the amount of ABCC1. 2 / 2

INDRA sources:

Databases

Reading